| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | 
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Total Revenue | 493.24B | 495.56B | 442.23B | 398.37B | 352.25B | 318.35B | 
| Gross Profit | 358.23B | 362.95B | 331.03B | 311.46B | 264.40B | 237.91B | 
| EBITDA | 91.27B | 105.40B | 118.53B | 82.81B | 75.22B | 73.03B | 
| Net Income | 38.41B | 59.87B | 81.19B | 53.57B | 52.35B | 47.03B | 
| Balance Sheet | ||||||
| Total Assets | 1.07T | 1.07T | 1.03T | 939.88B | 921.87B | 801.29B | 
| Cash, Cash Equivalents and Short-Term Investments | 234.60B | 244.68B | 405.01B | 339.72B | 336.52B | 287.65B | 
| Total Debt | 23.00B | 21.68B | 24.25B | 23.28B | 22.54B | 779.00M | 
| Total Liabilities | 224.53B | 216.55B | 189.52B | 177.06B | 184.71B | 102.89B | 
| Stockholders Equity | 841.98B | 850.81B | 836.42B | 762.83B | 737.16B | 698.40B | 
| Cash Flow | ||||||
| Free Cash Flow | 26.98B | 41.85B | 82.70B | 20.01B | 66.78B | 4.27B | 
| Operating Cash Flow | 60.87B | 67.88B | 115.55B | 48.67B | 86.55B | 39.50B | 
| Investing Cash Flow | -96.63B | -142.39B | -20.38B | -17.18B | -11.36B | 252.56B | 
| Financing Cash Flow | -38.69B | -84.70B | -32.53B | -29.03B | -28.45B | -26.00B | 
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth | 
|---|---|---|---|---|---|---|---|
| ― | $11.31T | 28.63 | 20.99% | 1.41% | 6.25% | 2.62% | |
| ― | $2.15T | 11.39 | 12.22% | 2.54% | 4.48% | 11.08% | |
| ― | $7.65T | 25.33 | 18.32% | 1.51% | 14.09% | 31.96% | |
| ― | $2.89T | 35.26 | 5.46% | 4.61% | 14.29% | 368.64% | |
| ― | $1.28T | 25.44 | 5.96% | 3.49% | 9.43% | 56.53% | |
| ― | $1.17T | 30.49 | 4.61% | 2.57% | 3.62% | -59.69% | |
| ― | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | 
Kyowa Kirin Co. recently held its earnings call, presenting a mixed sentiment with both notable achievements and ongoing challenges. The company reported significant growth in key products like Crysvita and Poteligeo, alongside promising advancements in research and development. However, these positives were tempered by decreased revenue and profits, largely due to restructuring impacts in Japan and the APAC region.